Back
Monopar Therapeutics Stock Price Chart
Gold Set to Skyrocket as Fed Slashes Rates
Click here for the details on this incredible opportunity.
Buy
65
MNPR
Monopar Therapeutics
Last Price:
21.71
Seasonality Move:
7.43%
7 Day Trial
ALL ACCESS PASS
$
7
Escape the market madness with 7 stocks to buy and hold
Get the complete list FREE for a limited time.- Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MNPR is experiencing buying pressure, which is a positive indicator for future bullish movement.
Monopar Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 8.64 | Buy |
| 20-day SMA: | 6.69 | Buy |
| 50-day SMA: | 4.51 | Buy |
| 200-day SMA: | 3.61 | Buy |
| 8-day EMA: | 11.25 | Buy |
| 20-day EMA: | 7.63 | Buy |
| 50-day EMA: | 5.48 | Buy |
| 200-day EMA: | 4.09 | Buy |
Monopar Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.46 | Buy |
| Relative Strength Index (14 RSI): | 93.57 | Buy |
| Chaikin Money Flow: | 12436621 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.85 - 11.69) | Buy |
| Bollinger Bands (100): | (0.99 - 7.11) | Buy |
Monopar Therapeutics Technical Analysis
| Oct 10 | Oct 11 | Oct 14 | Oct 15 | Oct 16 | Oct 18 | Oct 21 | Oct 22 | Oct 23 | Oct 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | ||||||||||
| 10 | 11 | 14 | 15 | 16 | 18 | 21 | 22 | 23 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Monopar Therapeutics Stock
Is Monopar Therapeutics Stock a Buy?
- Monopar Therapeutics share price is 32.66 while MNPR 8-day simple moving average is 8.64, which is a Buy signal.
- The stock price of MNPR is 32.66 while Monopar Therapeutics 20-day SMA is 6.69, which makes it a Buy.
- Monopar Therapeutics 50-day simple moving average is 4.51 while MNPR share price is 32.66, making it a Buy technically.
- MNPR stock price is 32.66 and Monopar Therapeutics 200-day simple moving average is 3.61, creating a Buy signal.
MNPR Technical Analysis vs Fundamental Analysis
Buy
65
Monopar Therapeutics (MNPR)
is a Buy
Is Monopar Therapeutics a Buy or a Sell?
-
Monopar Therapeutics stock is rated a Buy
The current Monopar Therapeutics [MNPR] share price is $32.66. The Score for MNPR is 65, which is 30% above its historic median score of 50, and infers lower risk than normal.
Monopar Therapeutics Stock Info
Market Cap:
114.98M
Price in USD:
32.66
Share Volume:
19.05M
Monopar Therapeutics 52-Week Range
52-Week High:
38.50
52-Week Low:
1.37
Buy
65
Monopar Therapeutics (MNPR)
is a Buy
Monopar Therapeutics Share Price Forecast
-
What is the Monopar Therapeutics stock price today?
The Monopar Therapeutics stock price is 32.66 USD today. -
Will MNPR stock go up or go down?
Monopar Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Monopar Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Monopar Therapeutics is not overvalued.
Is Monopar Therapeutics Stock a Buy?
- Monopar Therapeutics share price is 32.66 while MNPR 8-day exponential moving average is 11.25, which is a Buy signal.
- The stock price of MNPR is 32.66 while Monopar Therapeutics 20-day EMA is 7.63, which makes it a Buy.
- Monopar Therapeutics 50-day exponential moving average is 5.48 while MNPR share price is 32.66, making it a Buy technically.
- MNPR stock price is 32.66 and Monopar Therapeutics 200-day simple moving average is 4.09, creating a Buy signal.
Fundamental Analysis of Monopar Therapeutics
Is Monopar Therapeutics a good investment?
- Analysts estimate an earnings decrease this quarter of $0.27 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.34 per share, and a decrease next year of $0.21 per share.
Technical Analysis of Monopar Therapeutics
Should I short Monopar Therapeutics stock?
- MNPR Moving Average Covergence Divergence (MACD) indicator is 2.46, suggesting Monopar Therapeutics is a Buy
- Monopar Therapeutics Relative Strength Index (RSI) is 93.57, which suggest Monopar Therapeutics is overbought
- The Bollinger Bands (25) for Monopar Therapeutics is (0.85 - 11.69), which suggest Monopar Therapeutics is a Buy
- The Bollinger Bands (100) for Monopar Therapeutics is (0.99 - 7.11), which suggest Monopar Therapeutics is a Buy
* Monopar Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.